Winner Medical Future Growth
Future criteria checks 4/6
Winner Medical is forecast to grow earnings and revenue by 72.5% and 16.6% per annum respectively. EPS is expected to grow by 72.5% per annum. Return on equity is forecast to be 8.7% in 3 years.
Key information
72.5%
Earnings growth rate
72.5%
EPS growth rate
| Medical Equipment earnings growth | 25.9% |
| Revenue growth rate | 16.6% |
| Future return on equity | 8.7% |
| Analyst coverage | Good |
| Last updated | 15 Dec 2024 |
Recent future growth updates
Recent updates
Winner Medical Co., Ltd. (SZSE:300888) Stock Rockets 25% But Many Are Still Ignoring The Company
Dec 12
Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?
Nov 21Winner Medical Co., Ltd.'s (SZSE:300888) Shares Lagging The Industry But So Is The Business
Sep 16Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)
Aug 19Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital
Aug 02Is Winner Medical (SZSE:300888) Using Too Much Debt?
Jul 15Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year
May 31There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings
May 01There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital
Apr 26Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)
Apr 08Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?
Mar 17There's No Escaping Winner Medical Co., Ltd.'s (SZSE:300888) Muted Earnings
Feb 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 11,898 | 1,199 | 1,068 | 924 | 5 |
| 12/31/2025 | 10,530 | 1,031 | 876 | 1,617 | 6 |
| 12/31/2024 | 8,754 | 829 | 2,271 | 615 | 6 |
| 9/30/2024 | 8,245 | -1,014 | 492 | 1,329 | N/A |
| 6/30/2024 | 7,952 | 283 | 333 | 1,098 | N/A |
| 3/31/2024 | 7,742 | 386 | 393 | 1,123 | N/A |
| 12/31/2023 | 8,185 | 580 | 310 | 1,063 | N/A |
| 9/30/2023 | 9,719 | 2,548 | 1,059 | 1,998 | N/A |
| 6/30/2023 | 10,460 | 1,440 | 1,231 | 2,341 | N/A |
| 3/31/2023 | 11,381 | 1,671 | 1,206 | 2,363 | N/A |
| 1/1/2023 | 11,351 | 1,651 | 1,784 | 2,983 | N/A |
| 9/30/2022 | 9,860 | 1,386 | 555 | 1,650 | N/A |
| 6/30/2022 | 9,135 | 1,371 | 546 | 1,475 | N/A |
| 3/31/2022 | 8,091 | 1,116 | 348 | 1,081 | N/A |
| 1/1/2022 | 8,037 | 1,239 | 128 | 872 | N/A |
| 9/30/2021 | 8,831 | 1,764 | 569 | 1,233 | N/A |
| 6/30/2021 | 12,414 | 3,539 | 1,745 | 2,492 | N/A |
| 3/31/2021 | 13,320 | 3,972 | 3,641 | 4,344 | N/A |
| 12/31/2020 | 12,534 | 3,810 | 4,194 | 4,767 | N/A |
| 9/30/2020 | 10,979 | 3,292 | 3,820 | 4,289 | N/A |
| 6/30/2020 | 6,649 | 1,349 | 2,497 | 2,828 | N/A |
| 3/31/2020 | 5,005 | 750 | 569 | 1,089 | N/A |
| 12/31/2019 | 4,575 | 546 | 153 | 600 | N/A |
| 12/31/2018 | 3,839 | 425 | -170 | 468 | N/A |
| 12/31/2017 | 3,498 | 427 | N/A | 358 | N/A |
| 12/31/2016 | 2,560 | 410 | N/A | 450 | N/A |
| 12/31/2015 | 1,819 | 221 | N/A | 269 | N/A |
| 12/31/2014 | 1,510 | 129 | N/A | 204 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300888 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).
Earnings vs Market: 300888 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300888 is expected to become profitable in the next 3 years.
Revenue vs Market: 300888's revenue (16.6% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 300888's revenue (16.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300888's Return on Equity is forecast to be low in 3 years time (8.7%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 21:56 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Winner Medical Co., Ltd. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fu Yang | Chasing Securities |
| Zhuonan Xu | China International Capital Corporation Limited |
| Junhao Fan | China International Capital Corporation Limited |